To explore the anti-tumor mechanism underlying antiproliferative activity of the compound-7g in human glioblastoma cells, the expression level of E3 ubiquitin ligase SKP2 was detected by immunoblotting in both U87 and LN229 cells after treatment with the inhibitor. This evidence concerns the gene SKP2 and glioblastoma.